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Teaser  
Modern translations provide a new opportunity to revisit the Anglo-Saxon medicinal 
texts, a valuable resource for discovering and developing novel compounds from 
native British flora. 
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Abstract  
 Three Anglo-Saxon manuscripts reporting medicinal formulations in England from 
the tenth century survive: the ‘Old English Herbarium’, Bald’s Leechbooks and 
‘Lacnunga’ which may contain new leads and insights into new medicinal uses. 
Previous pharmacological studies of 16th and 17th century medicinal plants reported 
in the Anglo-Saxon medical texts, suggest some were effective and led to the 
identification and isolation of new natural compounds such as matricin from Achillea 
millefolium L., a prodrug that yields chamazulene carboxylic acid, a natural profen. 
New insights through multidisciplinary projects could further explore the manuscript 
content for the discovery of metabolites with potential pharmacological applications. 
 
Introduction  
In cancer drug development over 47% of small molecules used today originate from 
flowering plants or are synthetic derivatives [1]. Chinese and Indian cultures consider 
ancient texts of medicinal plants to be valuable resources in the search for novel 
compounds with potential pharmacological applications.  Whereas in England, the 
Anglo-Saxon medical manuscripts have been much maligned until recent years, 
where new translations of the ancient texts have provided greater access to the 
Anglo-Saxon pharmacopoeia for scientific investigation of this indigenous herbal 
tradition [2]. There have been studies of British medicinal plants appearing in later 
herbals although these formulations are greatly influenced by European, Arabic and 
Mediterannean pharmacopoeias of the time [3].  
 
The Anglo-Saxon period spanned over 500 years from AD 499-1066. King Alfred 
(AD 871-899) was responsible for the foundation of English law and commissioned 
the Anglo-Saxon Chronicle, to record major events and natural phenomenon from 
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the time of Christ [4]. There is supporting evidence for the ‘little optimum’ or Medieval 
Warm Period, thought to be similar to current day British weather patterns, with 38 
established English vineyards listed in the Domesday survey of 1086 [5]. 
 
For more than half a millennium battles, disease, droughts and famines in Anglo-
Saxon England created great demands upon human health and the physicians 
attending the wounded and the sick. Leech or ‘laece’ is an Old English word for  
healer or doctor. The Anglo-Saxon leech would have had many written sources at 
his disposal including Latin and Greek medical books [6,7,8] and a prior knowledge 
of plants and herbal practices would have been required to make effective use of the 
herbal texts, to confidently treat disease and charge a laecefoh or ‘doctor’s fee’ for 
services and medication [8]. 
 
Some of the Anglo-Saxon settlements were near swamps and marshes resulting in 
people suffering from asthma, eye and ear infections, pleurisy and rheumatism. 
Spring fever, now thought to have been malaria, was recorded in the eighth century 
by the venerable Bede, historian and theologian, and remained evident throughout 
the Anglo-Saxon period. Disease encompassed plague and leprosy; battle wounds, 
amputations and burns; rheumatism, viral infections or ‘flying venoms’ and a variety 
of parasites, especially ‘burrowing worms’ [7, 9] . The most common remedies found 
in the Anglo-Saxon medical texts are for skin disease, cough or lung disease, eye 
problems, headaches and fevers [10]. 
 
Treatment was empirical, pragmatic and according to Cameron [7] two thirds of the 
remedies would have been effective for the prescribed condition. Internal and 
external applications were made from the whole plant or specified parts prepared as 
infusions, decoctions in wine or ale and pounded in animal grease for ointments, 
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salves and poultices. Formulas comprised ‘simples’ or single plant remedies as well 
as combination formulas [11] (vol 1, p11). Constant eye, skin and urinary problems 
suggest that people were more likely to be deficient in vitamin A during the winter 
months and also vitamin C, resulting in bleeding gums, scurvy, ulcers and dysentery. 
Exotic fruit and spices were highly valued and by the end of the tenth century, 
London was a vibrant trade centre exchanging goods from Europe, Africa and the 
East  [5,12].  
 
Anglo-Saxon Medical Manuscripts  
Today, over one thousand pages of medical texts compiled in the vernacular survive 
of which three major works, the Old English herbarium (AD 950), Bald’s Leechbooks 
(AD 950-1000) and ‘Lacnunga’ (AD 1000) describe common conditions affecting 
human and animal health and their treatments during the ninth and tenth century 
[10]. 
 
The Old English Herbarium (British Library, Cotton Vitellius C.III) is believed to be a 
compilation of earlier European Latin texts that was in circulation in England during 
the 8th century, translated and reordered in Old English with Anglo-Saxon names 
allocated to many of the plants. At least four copies are known to have existed at the 
same time in Anglo-Saxon England illustrating that it was considered an important 
medical text possibly in general circulation to physicians [13]. Some plants illustrated 
are of Mediterranean origin and would not have grown in England although of the 
185 plants included, 140 were given an Old English name alongside the Latin or 
Greek reference [7,8]. 
 
It is believed Bald’s Leechbooks (British Library, MS Royal, 12.D.XVII) were 
commissioned by Bald around AD 950 [6,8] to assimilate the best of medical 
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knowledge from classical sources into Old English; a unique practice not witnessed 
anywhere in mainland Europe during this period [2,14]. Books I and II begin with a 
number of remedies for each condition starting at the head and moving down the 
body towards the toes; the first book is complete and concerned with mainly external 
complaints. The second, a book of the ‘inwards’, shows some anatomical 
understanding of liver function and external symptoms of internal complaints whilst 
the third is thought to be of an earlier period as there is less Mediterranean influence 
in the formulations [15] (Bk II p.221). Generally, recipes include a list of plant names 
with brief directions, ‘Oxa taught us this leechdom’ implying that the person 
compiling the formulation would have had prior knowledge of how to prepare the 
mixture [15] (p.121).  
 
A lesser known, and anonymous, semi-complete collection of 193 pages commonly 
referred to as ‘Lacnunga’ (British Library, MS Harley 585) is believed to have been 
compiled around AD1000 and lists more than 240 Old English plant names. It is a 
collection of formulations from many different sources and may have been a 
‘commonplace’ book or a lay person’s collection as it contains many errors and 
inconsistencies [8].  Lacnunga does include remedies from all three Leechbooks 
although Pettit (2001) considers the collection to be derived from another exemplar 
now lost. Some 300 plants are reported across the three manuscripts with many still 
used in Western herbal medicine including A. millefolium, Marrubium vulgare L. and 
Hypericum perforatum L. [16]. 
 
Recent Translations Illuminate Anglo-Saxon Medical Practice  
During the nineteenth century the philologist Thomas Oswald Cockayne of King’s 
College London, achieved a monumental task in translating all known medical Anglo-
Saxon manuscripts into modern English [13]. For nearly a century there was a denial 
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that the Anglo-Saxon texts had anything of value to offer the medical profession and 
were, according to Wilfrid Bonser, an archivist and historian, ‘sterile formulas, which 
could be applied without any exercise of reasoning, alone survived for use during the 
Dark Ages’ [7]. During the 1960’s attitudes began to change with scholars compiling 
new translations, thus opening the door for scientific investigation of the potential 
value of plants used in these historical texts [7,8,10,11,13]. 
 
Scholars have hotly debated the correct identity of plants cited in the texts 
particularly as, in some cases, the accompanying illustrations differ to the plants 
described; refer to a subsequent remedy or could be simply, an incorrect translation 
of the original text and presents one of the main barriers to the recovery of the plant 
identification [7,10,17]. Confusion also arises where the Anglo-Saxons used the 
same name for different plants. Brown plant or ‘brunwyrt’ may refer to some visual 
aspect of the plant being brown or, a disease of the mouth and throat and often, the 
converse was true, one plant having many different common names. The 
formulations give different medicinal uses for different parts of the plant including the 
leaves, flowers, roots, seeds, juice [7,8] and in some instances, the whole plant is 
specified as in a wound salve ‘…the nether and upward part of agrimony, boil in ale, 
barm them with yeast’ [15] (p.97). 
 
Economic botany was a consideration for the lay physician who would have relied 
upon locally grown plants for the mainstay of his pharmacopeia and substituted 
species according to the local terrain e.g. Plantago major L. grows well in clay but in 
sandy soil P. media would be chosen. There was an awareness that the potency of 
plants varies during the growth cycle and the texts, where considered important, give 
specific instructions for harvesting [7,13]; a study of H. perforatum showed aerial 
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parts did not display any antimicrobial activity when harvested in July compared to 
activity present when collected in August [17]. 
 
Bioactive Metabolites from Anglo-Saxon Medicinal Plants 
Evidence suggests some plants used in Anglo-Saxon remedies indeed have 
pharmacological actions relevant for treating the conditions cited in the ancient 
medical texts [7]. One Leechbook remedy for spleen pain, states ‘pound green willow 
bark, boil it alone in honey, give it to him to eat, three pieces, having fasted 
overnight’[8] (p.387). Aspirin, a synthetic derivative from Salix alba L. or willow bark 
was patented in 1900 and sold as a tablet to relieve headache, muscular and joint 
pain. Papaver somniferum L. or white poppy in the Old English herbarium was 
recommended for eye pain, headache and sleeplessness ‘take the juice of the plant, 
rub it on the person and you will quickly give him sleep’ [13] (p.173). The greatest 
contribution to medicine has been the alkaloid group with codeine, morphine and 
thebaine all isolated from the white poppy [18]. A large number of plants were used 
in treating wounds including Hedera helix L. or ivy leaf and although it is no longer 
used in Western herbal medicine it is an important herb in European herbal 
medicine, particularly Germany, for treating respiratory conditions. A postmarketing 
study of 9657 patients taking ivy leaf syrup extract for bronchitis showed 95% 
improvement after 7 days administering herbal preparation [19]. Three native British 
plants from the ancient medical texts that have been well researched for their 
phytochemical potential are A. millefolium, M. vulgare and H. perforatum. Taken 
together, these in vitro and in vivo studies reveal bioactive constituents, often the 
major constituents, underlying the Anglo-Saxon medicinal uses.   
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A. millefolium, (Asteraceae), Yarrow  
Yarrow is an aromatic perennial plant native to the British Isles and found in 
grassland habitats from sea-level to 1210m. The common name is derived from the 
Anglo-Saxon word ‘gearwe’, modern synonyms including bloodwort, nosebleed and 
herba militaris which all refer to its traditional use as a wound herb [20].  It was an 
Anglo Saxon plant of choice for healing wounds, swellings and rashes on the face, 
headaches, intestinal and abdominal pain, heartburn, difficult digestion, diarrhoea, 
snake and dog bites. The roots were also eaten on an empty stomach for toothache 
[13] (p.187). Modern applications include treating digestive problems, liver and gall 
bladder conditions, cramps, dysmenorrhoea and fever.  In Germany yarrow flower is 
licensed as a standard medicinal tea and in the USA it is used as a diaphoretic or 
febrifuge component of traditional cold and flu/fever compounds marketed as dietary 
supplements [20].  Recent pharmacological studies of plant extracts from all parts of 
A. millefolium have demonstrated anti-inflammatory properties [21,22], 
antileishmanial activity of oil from leaves and flowers [23] and in vivo antinociceptive 
effects [24]. Known A. millefolium constituents include matricin and other proazulenic 
sesquiterpene lactones known to yield chamazulene carboxylic acid (Fig. 1.), an anti-
inflammatory natural profen which can inhibit COX-2 and has been used for the 
semi-synthesis of analogues as potential anti-inflammatory drugs [25,26]. The 
flavonoid constituent casticin (vitexicarpin) shows a moderate inhibition in the 
reduction of a water soluble tetrazolium salt and a strong inhibition of lipooxygenase 
with an IC50 value of 26 μM [27]. In terms of modern drug discovery and the search 
for chemical diversity from sustainable natural product sources, there exist 
opportunities to mine A. millefolium for more minor constituents and current diseases 
not indicated by the Anglo-Saxon manuscripts. One recent example on the 
antitumoral effect of casticin showed two MCF-7-derived breast cancer cell lines 
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MN1 and MDD2, inducing a significant G2/M cell cycle arrest and induction of 
apoptosis via a multiple mechanism independent of p53 mutation [28].   
 
M. vulgare, (Lamiaceae), White horehound   
Marrubium or white horehound, a native to the British Isles, is found on short 
grassland, open or rough ground. The plant is listed in all three manuscripts for 
treating coughs, cold, snake bite or poisonings; a common occurrence with people 
collecting wild foods from the hedgerows. One remedy for cough says ‘boil 
marrubium in water, a good deal of it, sweeten a little, give the man to drink a cup 
full’ [15] (p315). The plant is a bitter tonic, expectorant, hypotensive, purgative, 
emetic and a vermifuge. Today it is traditionally used in Western herbal medicine as 
a daily dose equivalent to 4.5g herb, primarily for treating bronchitis and asthma [20]. 
Biological activity studies have shown that the alcoholic root extract of M. vulgare is 
a potent inhibitor of biofilm formation and adherence of MRSA with IC50 values of 
32µg/mL and 8µg/mL respectively [29], which can explain the Anglo-Saxon uses for 
treating battle wounds [11,13]. Other in vitro studies have also demonstrated the 
hypoglycaemic, analgesic and antispasmodic effects of extracts from this plant [30]. 
The main chemical component in M. vulgare, is marrubiin, a labdane diterpene 
isolated from acetone and ethanol extracts of this plant [31]. Marrubiin, marrubiinic 
acid and marrubenol (Fig. 1) have shown potent analgesic effects in vivo in the 
writhing test (10mg/kg, i.p.) by reducing abdominal constrictions by 92, 80 and 94% 
respectively [30,32]. The observed analgesic effects can also be associated to the 
Anglo-Saxon use of this plant in treating stomach ache, painful and swollen joints 
and all stiffness in the body [13]. Marrubenol has also been shown to have a 
vasorelaxant activity induced by the blocking of L-type voltage-dependant calcium 
(Ca2+) channels present in smooth muscle [33]. It has been demonstrated that 
vasorelaxation is essential for angiogenesis, an important process in wound healing 
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[34]. Another constituent in M.vulgare is ladanein (Fig.1), a methylated flavone which 
has shown in vitro cytotoxic activity against dasatinib-resistant leukaemia cells but 
inactive against human peripheral blood mononuclear cells or human monocytic 
leukaemia cells [35]. Additionally, because of its growth inhibition activity against 
chloroquine-sensitive P.falciparum (IC50=9µM), ladanein was recently used as a 
template to design a pharmacophore to target the biosynthesis of fatty acids of this 
protozoan organism [36]. Another Anglo-Saxon use was to wash scabs, impetigo 
and ringworm with a decoction of the aerial parts [13] (p.170). Verbascoside, a 
phenylpropanoid glycoside (Fig.1), has shown to be active against both Gram 
positive and Gram negative bacterial strains and also isolated as one of the 
antibacterial metabolites in Marrubium globosum and the active antibacterial 
metabolite of Buddleja globosa [37,38]. 
 
H.  perforatum, (Hypericaceae), St. John’s Wort  
 St. John’s Wort or hypericum is a rhizomatous perennial native to the British Isles 
and found in dryish grassland, banks and open woodland. The Old English 
herbarium formulation for H. perforatum is to ‘pound the plant and drink to stimulate 
urination’, yet ‘pound in wine and give to drink for a quartan fever ‘[13]. The plant 
also had a reputation for purifying and strengthening other plant formulations [8]. H. 
perforatum has been traditionally used as an aromatic, expectorant, anxiolytic, 
sedative and anti-inflammatory to treat bladder complaints, chronic catarrh, colds, 
diarrhoea, jaundice, rheumatism, menopause, worms and nervous depression 
[16,39]. H. perforatum has been widely tested in vivo and in vitro for a variety of 
pharmacological effects such as antibacterial, anti-inflammatory [40],  wound-healing 
[41,42], antitumoral [43], antiviral [44], inhibition of dopamine and norepinephrine 
reuptake  [45], reduction of neuropathic pain  [46] and treatment of mild-to-moderate 
depression [47,48] among others. Hydroalcoholic extracts of H. perforatum contain 
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naphtodianthrones, flavonoids, phenylpropanes, phloroglucinols, proanthocyanidins 
secondary, tannins [40] but it is known that the activities mentioned before are 
mainly mediated by a single or a combination of hypericin, pseudohypericin and/or 
hyperforin (Fig. 1). Hypericin is considered a potential new tool for the photodynamic 
therapy of cancer [44].  Hyperforin is known to be the key contributing metabolite for 
antidepressant activity and the main metabolite responsible for the antibacterial 
activity [40,47]. Other plants now known to have therapeutic properties and used in 
drug development (Table 1) were evident in the Anglo-Saxon formulations and with 
closer inspection, the texts could provide further insights into additional 
pharmacological compounds from native British plants. 
 
Conclusion and future perspectives 
The stylistic illustrations in the Old English herbarium have been criticised for being 
too simplistic, yet are reflective of dried plants in herbarium specimens and would 
have been useful references to persons harvesting plant material from the wild or 
receiving dried material from overseas [6,13]. There were different types of medical 
literature ranging from the gold standard Leechbooks of Bald, combining the best of 
classical and indigenous teachings into a coherent text suitable for attending the 
royal household in Anglo-Saxon England. ‘Lacnunga’ on the other hand is 
considered to be a lay physician’s ‘work in progress’ or personal collection from the 
general formulations in circulation at the time [8,11]. The monasteries compiled their 
own medicinal literature comprising simple manuals for monks to attend the sick [9]. 
Plants allocated an Anglo-Saxon name in the Old English herbarium would have 
been considered more noteworthy than those without and, if not grown in England, 
available through foreign trade and monastic exchanges [7,12]. In later herbals, 
Culpeper [49] wrote that dandelion did not warrant a written description as it was 
known everywhere, showing that common knowledge of formulations was often 
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glossed over or omitted and subsequently would be lost to future generations. Plant 
diversity changes with evolving agricultural methods as seen recently with Betonica 
officinalis L. or betony [50]. This plant was popular with Anglo-Saxons and must have 
been readily available with over 29 single formulations in the Old English herbarium 
[13,15]. Betony favours impoverished hay meadows and in the last twenty five years 
has significantly declined in southern England [50]. With hindsight and the scientific 
evidence base still evolving, many of the ancient herbal formulations seem rational. 
In some cases, formulations were improved upon by adding plants to improve the 
efficacy. In Leechbook III a remedy previously seen in the Old English herbarium had 
been altered to include wild garlic mustard to enhance the diuretic properties of the 
formulation [2]. Some plants continue to be used in Western herbal medicine whilst 
others are no longer prescribed. Perhaps because of changing trends as new plants 
arrived from overseas; scarcity from over harvesting or a changing landscape; more 
effective plants found as a result of observations and knowledge exchanged through 
circulation of the medical manuscripts. Whatever the reason, certain plants fell by the 
wayside that could be pharmacologically active. There is evidence to suggest that 
the Anglo-Saxon texts as a source for developing modern pharmaceuticals: Verbena 
officinalis L. or ‘berbene’ was prescribed for all kinds of poison with the plant 
powdered and given in a drink [13] (p.179) and one of the major constituents, 
verbascoside, exhibits a wide range of biological activity including antimicrobial, anti-
inflammatory and wound healing properties [51].  
 
Plant use for medicinal purpose is universal across all ancient cultures with many 
plants identified as having similar uses in the different pharmacopoeias. Others such 
as Isatis tinctoria L. or ‘wad’ leaves are listed in the Old English herbarium 
specifically for treating snakebite and whilst no longer used in Western herbal 
medicine, continues to be used in traditional Chinese medicine (TCM). The Anglo-
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Saxon era is often referred to as the Dark Ages and is widely perceived to have been 
a period of turbulence and lack of cultural development. The Anglo-Saxon 
pharmacopoeia reviewed here demonstrate an established system for administering 
plant-based treatments to the sick.  
The focus here has been small molecule chemistry although the use of plant 
biotechnology for crafting enzyme pathways in semi-synthesis is equally an area for 
further exploration such as the cell suspension culture of yarrow leaves  to produce 
melatonin [52]. In drug discovery the incremental development of high throughput in 
vitro biology and toxicology screens continues apace. However, the quest for 
molecular diversity remains limited by inaccessible chemistry routes and limited 
diversity of chemical scaffolds. Newer analytical tools for mining complex mixtures 
include hyphenated LC-NMR-MS spectroscopy [53] which enables greater access to 
active compounds that are minor constituents. Metabolomic mapping of 
pharmacological activity onto chemical features using multivariate data analysis is 
clearly a further relevant development [54]. However, the final frontier is arguably 
understanding the drug metabolism and pharmacokinetics aspects of novel classes 
of secondary metabolites, which can only fully be accessed though in vivo studies. 
Due to the perceived economic barriers to discovering drugs from plant natural 
products, there now exists an opportunity for truly multi-disciplinary research: social 
networks of linguists, botanists, herbalists, the medical profession and chemists to 
collaborate and recover those plants yet to be identified, as well as, investigate the 
pharmacological and medicinal uses of the known plants in the Anglo-Saxon 
pharmacopoeias [3,9].  
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Table1.0 Evidence of Other Plants in Anglo-Saxon Formulations 
Latin, Common 
and Anglo-
Saxon Plant 
Names 
Relevant Anglo-
Saxon Indications* 
Current Western 
Herbal Uses** 
Some Significant 
Constituents 
Reference 
Acorus calamus 
L. 
(Sweet Flag) 
Beowyrt 
Root decoction for 
urinary retention      
‘..within three days, 
the person will be 
able to pass urine..’ 
(p.150) 
Rhizome is used for 
stomach complaints 
such as gastritis, 
gastric ulcer, 
intestinal colic and 
dyspepsia.  Also an 
appetite stimulant in 
anorexia nervosa. a 
beta-asarone Kumar et al., [55] 
Shah and 
Giliani,[56] 
Chelidonium 
majus L. 
(Greater 
Celandine) 
Cyleenie 
Roots mashed in 
wine, honey and 
pepper ‘for dimness, 
pain and film in the 
eyes… apply to inner 
corners of the eyes’ 
(p.181) 
Ariel parts to treat 
jaundice, gallstones 
and gallbladder pain. 
Topically, the latex is 
applied to warts, 
tinea, eczema and 
verrucae. Subject to 
legal restrictions in 
the U.K. b 
Coptisine, 
chelerythrine, 
sanguinarine, 
chelidonine 
Kaminsky et al., 
[57] 
Hiller et al., [58] 
Colchicum 
autumnale  L. 
(Autumn crocus) 
Greate wyrt 
Salve from whole 
plant pounded in 
grease and oil 
applied to joints and  
a root infused oil for 
pimples on the nose 
(p.160) 
The dried corm is 
used to reduce joint 
inflammation and 
intense pain in acute 
gout.  Subject to 
legal restrictions in 
the U.K. b 
Colchicine,colchinol Yang, [59] 
Edwards et al., 
[60] 
Hyoscymus nigra 
L. 
(Henbane) 
Hennebelle or 
Belone 
Whole plant, juice, 
decoction in wine 
and salve for a 
variety of painful 
swellings of joints, 
toothache, genitals, 
breasts, sore feet 
and lung disease 
(p.148) 
Dried leaves and 
inflorescences used 
as a sedative and 
smooth muscle 
relaxant in cystitis, 
renal colic and for 
abdominal cramping. 
It is also used for 
spasmolytic actions 
in asthma and 
pertussis. Subject to 
legal restrictions in 
the U.K. b 
hyoscimine, 
scopolamine, atropine, 
cleomiscosin A (from 
seeds) 
Haas, [61] 
Begum et al., 
[62] 
Isatis tinctoria L. 
(Woad) Wad 
Mashed leaves 
applied directly to 
snakebite (p.180) 
Leaf extracts are 
used in Traditional 
Chinese Medicine to 
remove infections 
with excess heat, 
specifically 
encephalitis, upper 
respiratory infection 
and gastroenteritis. 
Root extracts, Ban 
Lang Gen have been 
used to treat patients 
with solid tumours 
and leukaemia. c 
tryptanthrin, 
glucobrassicin, 
indirubin 
Battstrom et al., 
[63] 
Mohn et al., [64] 
Plantago major 
L. 
(Greater 
Plantain) 
Waegbraede 
Whole plant, roots, 
juice and seed as 
decoctions, salve 
and poultices for 
wounds including 
snakebite, intestinal 
worms, painful 
The leaves have 
both diuretic and 
anti-haemorrhagic 
actions. Topically it is 
applied as an 
ointment or lotion to 
treat bleeding 
caffeic acid derivatives, 
flavonoids and iridod 
glycosides 
aucubin 
Samuelsen, [65] 
 
 
Cameron, [7] 
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headaches, swollen 
abdomen and hot 
inflammations and 
infected wounds, 
hard lumps, fever, 
gout,  (p.142) 
haemorrhoids, ulcers 
and chronic 
discharging skin 
eruptions such as 
scalds, burns and 
wounds that refuse 
to heal.  Internally it 
is used for conditions 
such as cystitis with 
haematuria, gastric 
ulcer, diarrhoea, 
irritable bowel 
syndrome and 
respiratory catarrh. b 
Sambucus 
ebulus L. 
(Dwarf elder) 
Wealwyrt or 
Ellenwyrt 
Whole plant pounded 
in wine for bladder 
stones and snakebite 
and pounded roots in 
wine for dropsy (p. 
190)* 
Although the anti-
inflammatory and 
anti-rheumatoid 
effects of the berry 
and rhizome extracts 
are well documented 
there is no current 
evidence of its 
medicinal use in 
Western countries. In 
traditional Iranian 
medicine it is used to 
treat inflammatory 
diseases including 
rheumatoid arthritis, 
infections and fever. 
d 
Quercetin-3-o-
glucoside; first 
example of “valeriana” 
acylated iridoid 
diglycosides bearing 
the uncommon D-
ribohexo-3-
ulopyranosyl sugar 
moiety; ribosome 
inactivating proteins 
Lectins, Nigrin B and 
Ebuline 1 transferrin 
conjugates 
Suntar et al., [66] 
 
Pieri, [67] 
 
 
 
Citores et al., 
[68] 
 
 * Anglo-Saxon Formulation Source [13] ** a) British Herbal Medicine Association [69]; b) Blumenthal, 
[20];   
   c)  Alternative Medicine Review [70] and d) Shokrzadeh et al. [71] 
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